Emily Barr
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Epidemiology top 2%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Papers in
- Hepatology 20
- Hepatitis C virus research 20
-
- HIV/AIDS drug development and treatment 19
- HIV/AIDS Research and Interventions 19
- Co-authors
- Jeffrey M. LeidenMin LüJohn F. ModlinBruce G. GellinGretchen TammsKevin BartonSandeep K. TripathyKaren Kozarsky
- Journals
- Journal of Hepatology (15 papers)The Journal of Infectious Diseases (5 papers)Clinical Infectious Diseases (3 papers)Infectious Diseases in Obstetrics and Gynecology (3 papers)AIDS (3 papers)
- Partner nations
- United StatesIsraelAustralia
In The Last Decade
Emily Barr
77 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 117
- Hepatology 308
- Epidemiology 1.1k
- Infectious Diseases 515
- Virology 81
- Genetics 441
Countries citing papers authored by Emily Barr
This map shows the geographic impact of Emily Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Barr more than expected).
Fields of papers citing papers by Emily Barr
This network shows the impact of papers produced by Emily Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Barr. The network helps show where Emily Barr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Barr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 12 | |
| 10 | 2018 | 76 | |
| 11 | 2018 | 43 | |
| 12 | 2016 | 17 | |
| 13 | High Sustained Virologic Response (SVR) Rates in Patients with Chronic HCV GT1, 2 or 3 Infection Following 16 Weeks of MK-3682/Grazoprevir/MK-8408 Plus Ribavirin After Failure of 8 Weeks of Therapy (Part C of C-CREST-1 & 2) | 2016 | 4 |
| 14 | 2015 | 1 | |
| 15 | 2015 | 13 | |
| 16 | 2008 | 23 | |
| 17 | 2008 | 3 | |
| 18 | 2007 | 255 | |
| 19 | 1998 | 3 | |
| 20 | 1998 | 22 |
About Emily Barr
Emily Barr is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Emergency Medicine, having authored 81 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (19 papers), HIV/AIDS Research and Interventions (19 papers), Hepatitis B Virus Studies (13 papers), Cervical Cancer and HPV Research (11 papers), Systemic Lupus Erythematosus Research (8 papers), HIV-related health complications and treatments (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Hepatology (308 citations), Epidemiology (1.1k citations), Infectious Diseases (515 citations), Virology (81 citations) and Genetics (441 citations). Emily Barr has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Jeffrey M. Leiden, Min Lü, John F. Modlin, Bruce G. Gellin, Gretchen Tamms, Kevin Barton, Sandeep K. Tripathy, Karen Kozarsky, Jessica Carroll and James M. Wilson. Their work appears in journals such as Journal of Hepatology, The Journal of Infectious Diseases, Clinical Infectious Diseases, Infectious Diseases in Obstetrics and Gynecology and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.